Cross-border converter
EMTAK 2025 21101 → CAEN Rev. 3 equivalent (Romania)
Estonia's national activity classification (EMTAK 2025) shares its 4-digit backbone with the EU NACE Rev 2.1 standard. We use that backbone to surface the equivalent CAEN Rev. 3 subclass(es) used in Romania.
Shared EU parent
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
21101
Põhifarmaatsiatoodete tootmine
211.0
Fabricarea produselor farmaceutice de bază
2110
Fabricarea produselor farmaceutice de bază
About this conversion
EMTAK 2025 is the activity classification used in Estonia. CAEN Rev. 3 is the equivalent system in Romania. Both are national implementations of EU NACE Rev 2.1, so any 5th-digit subclass in one system can be traced back to a shared 4-digit EU class — and from there, forward into the other country's subclasses.
This page is generated for the query "EMTAK 2025 21101 to CAEN Rev. 3" and stays in sync with our monthly Market Intelligence sync.